Financing, Equity Capital Markets

Fulcrum Therapeutics, Inc.

08/21
|
$144.2 Million
Piper Sandler served as bookrunner for Fulcrum Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma